KLOW

80mg

KLOW is a pre-blended four-peptide research vial containing KPV 10mg, BPC-157 10mg, TB-500 10mg and GHK-Cu 50mg, supplied as a single lyophilised powder for one-step reconstitution. KPV (Lysine-Proline-Valine, the active C-terminal tripeptide of alpha-melanocyte-stimulating hormone) is investigated for melanocortin-pathway anti-inflammatory effects in mucosal and gut-barrier research. BPC-157 (Body Protection Compound, 15-residue pentadecapeptide) and TB-500 (synthetic fragment of thymosin beta-4) are extensively co-investigated in soft-tissue, angiogenesis and cell-migration research. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is studied for collagen synthesis and copper-mediated tissue remodelling. KLOW pairs the GLOW regenerative trio with KPV's mucosal-research angle, covering both peripheral connective-tissue and barrier-immunity research models. Third-party tested, individual component purity reported on the lab certificate.

Published research on KLOW is indexed on PubMed.

Intended Use: Strictly for in-vitro laboratory research. Not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics. This product has not been evaluated by the MHRA or FDA. Buyer assumes full responsibility for safe handling and regulatory compliance.